Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Posch

Showing results (711-720 of 1,203) with videos related to

Pageof 121
Sort By:
Respiratory Research|February 28, 2024
P80 natural essence spray and lozenges provide respiratory protection against Influenza A, B, and SARS-CoV-2Viktoria Zaderer, Gabriel Diem, Wilfried Posch, et al.
Drug Discovery Today|October 28, 2017
Marketing authorisation of orphan medicines in Europe from 2000 to 2013Matthias P Hofer, Hanna Hedman, Maria Mavris, et al.
Head & Neck|December 23, 2017
Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgeryDaniel Dejaco, Teresa Steinbichler, Volker H Schartinger, et al.
Scientific Reports|May 26, 2023
Nationwide analysis of hospital admissions and outcomes of patients with SARS-CoV-2 infection in Austria in 2020 and 2021Paul Zajic, Michael Hiesmayr, Peter Bauer, et al.
The Journal of Hospital Infection|February 8, 2023
Antimicrobial efficacy and inactivation kinetics of a novel LED-based UV-irradiation technologyH Schöbel, G Diem, J Kiechl, et al.
Placenta|February 25, 2026
Reanimating the past: From historical collections of the placenta and uterus to modern imaging, machine learning, and multiscale modelingMalte Rolf, Sahan Jayatissa, Jonathan Reshef, et al.
Trials|November 21, 2018
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine AgencyOlivier Collignon, Franz Koenig, Armin Koch, et al.
Pharmaceutical Statistics|January 12, 2018
Approaches to sample size calculation for clinical trials in rare diseasesFrank Miller, Sarah Zohar, Nigel Stallard, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 7, 1999
Class I endochitinase containing a hevein domain is the causative allergen in latex-associated avocado allergyA Posch, C H Wheeler, Z Chen, et al.
Urology|May 1, 1999
Numerical chromosomal aberrations in muscle invasive squamous cell and transitional cell cancer of the urinary bladder: an alternative to classic prognostic indicators?A Pycha, C Mian, B Posch, et al.
Pageof 121

Showing results (711-720 of 1,203) with videos related to

Sort By:
Pageof 121
Respiratory Research|February 28, 2024
P80 natural essence spray and lozenges provide respiratory protection against Influenza A, B, and SARS-CoV-2Viktoria Zaderer, Gabriel Diem, Wilfried Posch, et al.
Drug Discovery Today|October 28, 2017
Marketing authorisation of orphan medicines in Europe from 2000 to 2013Matthias P Hofer, Hanna Hedman, Maria Mavris, et al.
Head & Neck|December 23, 2017
Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgeryDaniel Dejaco, Teresa Steinbichler, Volker H Schartinger, et al.
Scientific Reports|May 26, 2023
Nationwide analysis of hospital admissions and outcomes of patients with SARS-CoV-2 infection in Austria in 2020 and 2021Paul Zajic, Michael Hiesmayr, Peter Bauer, et al.
The Journal of Hospital Infection|February 8, 2023
Antimicrobial efficacy and inactivation kinetics of a novel LED-based UV-irradiation technologyH Schöbel, G Diem, J Kiechl, et al.
Placenta|February 25, 2026
Reanimating the past: From historical collections of the placenta and uterus to modern imaging, machine learning, and multiscale modelingMalte Rolf, Sahan Jayatissa, Jonathan Reshef, et al.
Trials|November 21, 2018
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine AgencyOlivier Collignon, Franz Koenig, Armin Koch, et al.
Pharmaceutical Statistics|January 12, 2018
Approaches to sample size calculation for clinical trials in rare diseasesFrank Miller, Sarah Zohar, Nigel Stallard, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 7, 1999
Class I endochitinase containing a hevein domain is the causative allergen in latex-associated avocado allergyA Posch, C H Wheeler, Z Chen, et al.
Urology|May 1, 1999
Numerical chromosomal aberrations in muscle invasive squamous cell and transitional cell cancer of the urinary bladder: an alternative to classic prognostic indicators?A Pycha, C Mian, B Posch, et al.
Pageof 121